Concentrix (CNXC) Projected to Post Quarterly Earnings on Thursday

Concentrix (NASDAQ:CNXC) will likely be issuing its Q2 2025 quarterly earnings data after the market closes on Thursday, June 26th. Analysts expect the company to announce earnings of $2.76 per share and revenue of $2.38 billion for the quarter.

Concentrix (NASDAQ:CNXC) last posted its earnings results on Wednesday, March 26th. The company reported $2.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.58 by $0.21. The company had revenue of $2.37 billion during the quarter, compared to analyst estimates of $2.37 billion. Concentrix had a return on equity of 16.73% and a net margin of 2.81%. The company’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same period in the previous year, the company earned $2.57 EPS.

Concentrix Stock Up 3.2%

Shares of NASDAQ CNXC opened at $51.77 on Tuesday. The stock has a market cap of $3.31 billion, a P/E ratio of 12.97, a P/E/G ratio of 0.65 and a beta of 0.56. The firm has a 50 day moving average price of $53.36 and a 200 day moving average price of $49.30. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.65 and a current ratio of 1.65. Concentrix has a 52-week low of $36.28 and a 52-week high of $77.00.

Concentrix Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 6th. Stockholders of record on Friday, April 25th were issued a $0.3328 dividend. This represents a $1.33 annualized dividend and a dividend yield of 2.57%. The ex-dividend date was Friday, April 25th. Concentrix’s dividend payout ratio (DPR) is 33.33%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CNXC shares. Bank of America boosted their target price on Concentrix from $59.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, June 9th. Barrington Research reduced their price target on shares of Concentrix from $70.00 to $54.00 and set an “outperform” rating for the company in a report on Monday, March 24th. Finally, Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday. Two research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Concentrix presently has a consensus rating of “Moderate Buy” and a consensus target price of $67.25.

Insiders Place Their Bets

In other Concentrix news, CEO Christopher A. Caldwell purchased 1,000 shares of the firm’s stock in a transaction on Monday, April 21st. The stock was purchased at an average cost of $46.00 per share, for a total transaction of $46,000.00. Following the acquisition, the chief executive officer now owns 303,362 shares in the company, valued at approximately $13,954,652. The trade was a 0.33% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Olivier Duha sold 29,444 shares of Concentrix stock in a transaction dated Tuesday, April 15th. The shares were sold at an average price of $48.52, for a total value of $1,428,622.88. Following the transaction, the director now owns 1,155,862 shares of the company’s stock, valued at $56,082,424.24. This trade represents a 2.48% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,944 shares of company stock valued at $1,510,158. 3.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of CNXC. Geneos Wealth Management Inc. raised its position in shares of Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares in the last quarter. Royal Bank of Canada increased its stake in shares of Concentrix by 9.5% in the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after buying an additional 4,133 shares during the period. Focus Partners Wealth purchased a new position in shares of Concentrix in the first quarter valued at about $781,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Concentrix by 17.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in shares of Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after buying an additional 181,546 shares during the period. Hedge funds and other institutional investors own 90.34% of the company’s stock.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.